Novartis executive sold shares before drug data manipulation made public 08.18.2019 · Posted in Business News Article An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug Administration (FDA) announced data from tests of its gene therapy Zolgensma had been manipulated. Tags: FDA